313 related articles for article (PubMed ID: 17438540)
1. New targets for obesity pharmacotherapy.
Aronne LJ; Thornton-Jones ZD
Clin Pharmacol Ther; 2007 May; 81(5):748-52. PubMed ID: 17438540
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine control of food intake.
Valassi E; Scacchi M; Cavagnini F
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414
[TBL] [Abstract][Full Text] [Related]
3. Current and investigational antiobesity agents and obesity therapeutic treatment targets.
Bays HE
Obes Res; 2004 Aug; 12(8):1197-211. PubMed ID: 15340100
[TBL] [Abstract][Full Text] [Related]
4. How the brain regulates food intake and body weight: the role of leptin.
Baskin DG; Blevins JE; Schwartz MW
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1417-29. PubMed ID: 11837495
[TBL] [Abstract][Full Text] [Related]
5. The neuronal histamine H(1) and pro-opiomelanocortin-melanocortin 4 receptors: independent regulation of food intake and energy expenditure.
Yoshimatsu H
Peptides; 2006 Feb; 27(2):326-32. PubMed ID: 16343692
[TBL] [Abstract][Full Text] [Related]
6. Manipulating central nervous mechanisms of food intake and body weight regulation by intranasal administration of neuropeptides in man.
Hallschmid M; Benedict C; Born J; Fehm HL; Kern W
Physiol Behav; 2004 Oct; 83(1):55-64. PubMed ID: 15501491
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation.
Ramos EJ; Meguid MM; Campos AC; Coelho JC
Nutrition; 2005 Feb; 21(2):269-79. PubMed ID: 15723758
[TBL] [Abstract][Full Text] [Related]
8. Clinical endocrinology and metabolism. Regulation of energy homeostasis by peripheral signals.
Woods SC; Benoit SC; Clegg DJ; Seeley RJ
Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):497-515. PubMed ID: 15533772
[TBL] [Abstract][Full Text] [Related]
9. Drug strategies for the treatment of obesity.
Alemany M; Remesar X; Fernández-López JA
IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
[TBL] [Abstract][Full Text] [Related]
10. [From gene defect to drug therapy for obesity?].
Grünewald-Funk D
Dtsch Med Wochenschr; 2003 May; 128(19):1034. PubMed ID: 12807110
[No Abstract] [Full Text] [Related]
11. [The YY3-36 peptide, a new therapeutic weapon against obesity?].
Jégou S; Mounien L; Boutelet I; Vaudry H
Med Sci (Paris); 2003 May; 19(5):537-9. PubMed ID: 12836385
[No Abstract] [Full Text] [Related]
12. The role of the endocannabinoid system in the control of energy homeostasis.
Osei-Hyiaman D; Harvey-White J; Bátkai S; Kunos G
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S33-8. PubMed ID: 16570103
[TBL] [Abstract][Full Text] [Related]
13. Gut peptides and other regulators in obesity.
Scharf MT; Ahima RS
Semin Liver Dis; 2004 Nov; 24(4):335-47. PubMed ID: 15605302
[TBL] [Abstract][Full Text] [Related]
14. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
Kunos G
Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
[TBL] [Abstract][Full Text] [Related]
15. Investigational therapies in the treatment of obesity.
Mancini MC; Halpern A
Expert Opin Investig Drugs; 2006 Aug; 15(8):897-915. PubMed ID: 16859393
[TBL] [Abstract][Full Text] [Related]
16. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
[TBL] [Abstract][Full Text] [Related]
17. A test of the lipostat theory in a seasonal (ovine) model under natural conditions reveals a close relationship between adiposity and melanin concentrating hormone expression.
Anukulkitch C; Rao A; Dunshea FR; Clarke IJ
Domest Anim Endocrinol; 2009 Apr; 36(3):138-51. PubMed ID: 19179037
[TBL] [Abstract][Full Text] [Related]
18. The role of the endocannabinoid system in the regulation of energy expenditure.
Cavuoto P; Wittert GA
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):79-86. PubMed ID: 19285262
[TBL] [Abstract][Full Text] [Related]
19. Emerging therapeutic strategies for obesity.
Foster-Schubert KE; Cummings DE
Endocr Rev; 2006 Dec; 27(7):779-93. PubMed ID: 17122357
[TBL] [Abstract][Full Text] [Related]
20. Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis.
Mashiko S; Moriya R; Ishihara A; Gomori A; Matsushita H; Egashira S; Iwaasa H; Takahashi T; Haga Y; Fukami T; Kanatani A
Eur J Pharmacol; 2009 Aug; 615(1-3):113-7. PubMed ID: 19482021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
